RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.32%)
As of: Sep 10, 2026 · 2:57 PM EDT

RenovoRx (RNXT) Total Debt (2020)

RenovoRx's (RNXT) quarterly Total Debt came in at $2.6 million in Q4 2020.

Analysis

RenovoRx (RNXT) Total Debt (2020) Analysis & Trends

RenovoRx has disclosed Total Debt across 1 years of filings, most recently posting $2.6 million for Q4 2020.

  • In Q4 2020, Total Debt changed N/A year-over-year to $2.6 million; the TTM figure through Dec 2020 stood at $2.6 million (changed N/A YoY), while the FY2020 annual figure was $2.6 million, changed N/A from the prior year.
  • Total Debt came in at $2.6 million for Q4 2020 at RenovoRx.
  • In the past five years, Total Debt ranged from a high of $2.6 million in Q4 2020 to a low of $2.6 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 180.77 Bn 175.17 Bn 7.27 Bn 32.61 Bn
2 Intuitive Surgical 127.65 Bn 122.43 Bn 1.96 Bn -
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 28.15 Bn
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 14.94 Bn
5 Boston Scientific 63.46 Bn 62.92 Bn 3.85 Bn 12.62 Bn
6 Edwards Lifesciences 49.73 Bn 45.48 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.01 Bn 31.56 Bn 1.68 Bn 4.15 Bn
8 Dexcom 32.17 Bn 30.22 Bn 830.00 Mn -
9 Steris 20.72 Bn 20.24 Bn 684.20 Mn 2.14 Bn
10 RenovoRx 84.43 Mn 84.43 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.65 Mn